Exosomes Market Study on Income, Statistics, Industry Development, and Demand by Emergen Research
Anonymous
98 x views • 3 years ago
Exosomes Market Forecast to 2030
The global exosomes market size reached USD 0.50 Billion in 2021 and is expected to register a revenue CAGR of 18% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of cancer, rapid scientific advancements in exosome research and technology development, improved exosome separation, characterization, and component detection methods, and increasing number of clinical studies and trials in the field of exosome-based research are some key factors driving market revenue growth.
The analysis provides accurate growth pattern estimates and looks at the factors influencing market growth in the global Exosomes market. The report's primary focus is on the key market constituents, including market drivers, restraints, opportunities, threats, risks, restrictions, and other factors. The research includes comprehensive studies of the company profiles, product portfolio, and corporate expansion strategies, in addition to a complete investigation of the competition landscape.
Exosomes have been progressively developed for disease therapy and diagnosis as the functions of exosomes in disease pathophysiological pathways have become understood. Exosome-mediated intercellular communication appears to have a role in the pathogenesis of a variety of diseases, including cancer, neurodegeneration, and other diseases.
Request a Sample Report with Table of Contents and Figures to visit this site @ https://www.emergenresearch.com/request-sample/1044
The global Exosomes market report employs an extremely extensive and perceptive process that analyzes statistical data relating to services and products offered in the market. The research study is a pivotal document in understanding the needs and wants of the clients. The report is comprised of significant data about the leading companies and their marketing strategies. The Exosomes industry is witnessing an expansion and change of dynamics owing to the entry of several new players.
The study outlines the rapidly evolving and growing market segments along with valuable insights into each element of the industry. The industry has witnessed the entry of several new players, and the report aims to deliver insightful information about their transition and growth in the market. Mergers, acquisitions, partnerships, agreements, product launches, and joint ventures are all outlined in the report.
QIAGEN, Takara Bio Company, Illumina, Inc., Thermo Fisher Scientific, Inc., Codiak Biosciences, Exosome Diagnostics, Evox Therapeutics, ExCoBio Inc., Bio-Rad Laboratories Ltd., and Beckman Coulter, Inc
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends @ https://www.emergenresearch.com/industry-report/exosomes-market
Some Key Highlights From the Report
Kits segment accounted for moderate revenue share in 2021. With the growing interest in the pathological and physiological aspects of exosomal miRNAs, commercial kits that promise easy and rapid isolation processes have been created and are now available for usage. Commercial kits are reliable, quick, and need little sample, making them excellent for identifying exosomal miRNA disease indicators. Some commercial kits identified a higher miRNA yield in serum exosomes than traditional approaches like ultrafiltration. Some of the widely used commercial exosome isolation kits include Total Exosome Isolation for serum or plasma (Invitrogen, MA, USA), RIBO Exosome Isolation Reagent (RIBO, Guangzhou, China), and ExoQuick Exosome Precipitation Solution (System Biosciences, CA, USA).
Neurodegenerative disease segment accounted for significantly robust revenue share in 2021. According to Alzheimer's dementia, in 2022, an estimated 6.5 million Americans aged 65 and older will be living with Alzheimer's and dementia, with 73% of those aged 75 or older. Alzheimer's Disease and dementia affects around one in every nine persons in the United States or 10.7% of the population. Alzheimer's affects a higher percentage of people as they get older, with 5.0%of persons aged 65 to 74, 13.1% of those aged 75 to 84, and 33.2% of people aged 85 and older having the disease. Exosomes have a role in intercellular communication, the maintenance of the myelin sheath, and the elimination of waste in the nervous system and they have been detected in cerebrospinal fluid and peripheral bodily fluids, which have demonstrated variations during disease progression. As a result, they have been increasingly used as biomarkers for identifying neurodegenerative disease progression, especially in Alzheimer's disease. For instance, exosomal amyloid peptides have also been found in the brain plaques of Alzheimer's Disease (AD) patients, and tau phosphorylated at Thr-181, a proven biomarker for AD, has been present at elevated levels in exosomes isolated from cerebrospinal fluid specimens of AD patients with mild symptoms
Market in Europe accounted for moderate revenue share in 2021. This is attributed to factors such as an increase in research and development efforts as well as government-funded research programs in the field of exosome based research. Furthermore, the growing presence of notable industry participants and others contributes significantly to the region's market growth. For instance, Evox Therapeutics Ltd. (‘Evox' or the 'Firm') has raised USD 95.4 million in a Series C funding transaction and this funding was highly oversubscribed, with both existing and new investors showing strong interest. Redmile Group led the Series C round, which was joined by additional investors OrbiMed and Invus. All existing Series B investors, including key backers Oxford Sciences Innovation (OSI), GV (previously Google Ventures), and Cowen Healthcare Investments, reinvested alongside Redmile. Its mission is to commercialize exosomes that have been optimized for function.
Market Overview:
The report bifurcates the Exosomes market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment.
Segments Covered in this report are:
Type Outlook (Revenue, USD Billion; 2019-2030)
Biomarkers
Drug Delivery Systems
Vaccine Development
Therapeutic Agents
Others
Product Type Outlook (Revenue, USD Billion; 2019-2030)
Kits
Reagents
Instruments
Application Outlook (Revenue, USD Billion; 2019-2030)
Cancer
Neurodegenerative Disease
Cardiovascular Diseases
Infectious Diseases
Tissue Regeneration
Others
Request a impresive discount on the report, click on here @ https://www.emergenresearch.com/request-discount/1044
The research report offers a comprehensive regional analysis of the market with regards to production and consumption patterns, import/export, market size and share in terms of volume and value, supply and demand dynamics, and presence of prominent players in each market.
Regional Analysis Covers:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Furthermore, the report provides the analytical data in an organized format segmented into charts, tables, graphs, figures, and diagrams. This enables readers to understand the market scenario in an easy and beneficial manner. Moreover, the report aims to impart a prospective outlook and draw an informative conclusion to assist the reader in making lucrative business decisions. The report, in conclusion, provides a detailed analysis of the segments expected to dominate the market, the regional bifurcation, the estimated market size and share, and comprehensive SWOT analysis and Porter’s Five Forces Analysis.
Request customization of the report @ https://www.emergenresearch.com/request-for-customization/1044
Thank you for reading our report. For further queries, please connect with us, and our team will provide you the report best suited to your requirements.
Latest Reports Published by Emergen Research:
human microbiome modulators market
https://www.emergenresearch.com/industry-report/human-microbiome-modulators-market
water storage systems market
https://www.emergenresearch.com/industry-report/water-storage-systems-market
agricultural lubricants market
https://www.emergenresearch.com/industry-report/agricultural-lubricants-market
mammography workstations market
https://www.emergenresearch.com/industry-report/mammography-workstations-market
cooling fabrics market
https://www.emergenresearch.com/industry-report/cooling-fabrics-market
cast elastomers market
https://www.emergenresearch.com/industry-report/cast-elastomers-market
membrane bioreactor market
https://www.emergenresearch.com/industry-report/membrane-bioreactor-market
quantum computing for enterprise market
https://www.emergenresearch.com/industry-report/quantum-computing-for-enterprise-market
iot chip market
https://www.emergenresearch.com/industry-report/iot-chip-market
internet of things insurance market
https://www.emergenresearch.com/industry-report/internet-of-things-insurance-market
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Latest Report: heart rhythm devices market, cancer tumor profiling market
Trending Title: pharmacogenomics market, cell-free dna testing market
The global exosomes market size reached USD 0.50 Billion in 2021 and is expected to register a revenue CAGR of 18% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of cancer, rapid scientific advancements in exosome research and technology development, improved exosome separation, characterization, and component detection methods, and increasing number of clinical studies and trials in the field of exosome-based research are some key factors driving market revenue growth.
The analysis provides accurate growth pattern estimates and looks at the factors influencing market growth in the global Exosomes market. The report's primary focus is on the key market constituents, including market drivers, restraints, opportunities, threats, risks, restrictions, and other factors. The research includes comprehensive studies of the company profiles, product portfolio, and corporate expansion strategies, in addition to a complete investigation of the competition landscape.
Exosomes have been progressively developed for disease therapy and diagnosis as the functions of exosomes in disease pathophysiological pathways have become understood. Exosome-mediated intercellular communication appears to have a role in the pathogenesis of a variety of diseases, including cancer, neurodegeneration, and other diseases.
Request a Sample Report with Table of Contents and Figures to visit this site @ https://www.emergenresearch.com/request-sample/1044
The global Exosomes market report employs an extremely extensive and perceptive process that analyzes statistical data relating to services and products offered in the market. The research study is a pivotal document in understanding the needs and wants of the clients. The report is comprised of significant data about the leading companies and their marketing strategies. The Exosomes industry is witnessing an expansion and change of dynamics owing to the entry of several new players.
The study outlines the rapidly evolving and growing market segments along with valuable insights into each element of the industry. The industry has witnessed the entry of several new players, and the report aims to deliver insightful information about their transition and growth in the market. Mergers, acquisitions, partnerships, agreements, product launches, and joint ventures are all outlined in the report.
QIAGEN, Takara Bio Company, Illumina, Inc., Thermo Fisher Scientific, Inc., Codiak Biosciences, Exosome Diagnostics, Evox Therapeutics, ExCoBio Inc., Bio-Rad Laboratories Ltd., and Beckman Coulter, Inc
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends @ https://www.emergenresearch.com/industry-report/exosomes-market
Some Key Highlights From the Report
Kits segment accounted for moderate revenue share in 2021. With the growing interest in the pathological and physiological aspects of exosomal miRNAs, commercial kits that promise easy and rapid isolation processes have been created and are now available for usage. Commercial kits are reliable, quick, and need little sample, making them excellent for identifying exosomal miRNA disease indicators. Some commercial kits identified a higher miRNA yield in serum exosomes than traditional approaches like ultrafiltration. Some of the widely used commercial exosome isolation kits include Total Exosome Isolation for serum or plasma (Invitrogen, MA, USA), RIBO Exosome Isolation Reagent (RIBO, Guangzhou, China), and ExoQuick Exosome Precipitation Solution (System Biosciences, CA, USA).
Neurodegenerative disease segment accounted for significantly robust revenue share in 2021. According to Alzheimer's dementia, in 2022, an estimated 6.5 million Americans aged 65 and older will be living with Alzheimer's and dementia, with 73% of those aged 75 or older. Alzheimer's Disease and dementia affects around one in every nine persons in the United States or 10.7% of the population. Alzheimer's affects a higher percentage of people as they get older, with 5.0%of persons aged 65 to 74, 13.1% of those aged 75 to 84, and 33.2% of people aged 85 and older having the disease. Exosomes have a role in intercellular communication, the maintenance of the myelin sheath, and the elimination of waste in the nervous system and they have been detected in cerebrospinal fluid and peripheral bodily fluids, which have demonstrated variations during disease progression. As a result, they have been increasingly used as biomarkers for identifying neurodegenerative disease progression, especially in Alzheimer's disease. For instance, exosomal amyloid peptides have also been found in the brain plaques of Alzheimer's Disease (AD) patients, and tau phosphorylated at Thr-181, a proven biomarker for AD, has been present at elevated levels in exosomes isolated from cerebrospinal fluid specimens of AD patients with mild symptoms
Market in Europe accounted for moderate revenue share in 2021. This is attributed to factors such as an increase in research and development efforts as well as government-funded research programs in the field of exosome based research. Furthermore, the growing presence of notable industry participants and others contributes significantly to the region's market growth. For instance, Evox Therapeutics Ltd. (‘Evox' or the 'Firm') has raised USD 95.4 million in a Series C funding transaction and this funding was highly oversubscribed, with both existing and new investors showing strong interest. Redmile Group led the Series C round, which was joined by additional investors OrbiMed and Invus. All existing Series B investors, including key backers Oxford Sciences Innovation (OSI), GV (previously Google Ventures), and Cowen Healthcare Investments, reinvested alongside Redmile. Its mission is to commercialize exosomes that have been optimized for function.
Market Overview:
The report bifurcates the Exosomes market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment.
Segments Covered in this report are:
Type Outlook (Revenue, USD Billion; 2019-2030)
Biomarkers
Drug Delivery Systems
Vaccine Development
Therapeutic Agents
Others
Product Type Outlook (Revenue, USD Billion; 2019-2030)
Kits
Reagents
Instruments
Application Outlook (Revenue, USD Billion; 2019-2030)
Cancer
Neurodegenerative Disease
Cardiovascular Diseases
Infectious Diseases
Tissue Regeneration
Others
Request a impresive discount on the report, click on here @ https://www.emergenresearch.com/request-discount/1044
The research report offers a comprehensive regional analysis of the market with regards to production and consumption patterns, import/export, market size and share in terms of volume and value, supply and demand dynamics, and presence of prominent players in each market.
Regional Analysis Covers:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Furthermore, the report provides the analytical data in an organized format segmented into charts, tables, graphs, figures, and diagrams. This enables readers to understand the market scenario in an easy and beneficial manner. Moreover, the report aims to impart a prospective outlook and draw an informative conclusion to assist the reader in making lucrative business decisions. The report, in conclusion, provides a detailed analysis of the segments expected to dominate the market, the regional bifurcation, the estimated market size and share, and comprehensive SWOT analysis and Porter’s Five Forces Analysis.
Request customization of the report @ https://www.emergenresearch.com/request-for-customization/1044
Thank you for reading our report. For further queries, please connect with us, and our team will provide you the report best suited to your requirements.
Latest Reports Published by Emergen Research:
human microbiome modulators market
https://www.emergenresearch.com/industry-report/human-microbiome-modulators-market
water storage systems market
https://www.emergenresearch.com/industry-report/water-storage-systems-market
agricultural lubricants market
https://www.emergenresearch.com/industry-report/agricultural-lubricants-market
mammography workstations market
https://www.emergenresearch.com/industry-report/mammography-workstations-market
cooling fabrics market
https://www.emergenresearch.com/industry-report/cooling-fabrics-market
cast elastomers market
https://www.emergenresearch.com/industry-report/cast-elastomers-market
membrane bioreactor market
https://www.emergenresearch.com/industry-report/membrane-bioreactor-market
quantum computing for enterprise market
https://www.emergenresearch.com/industry-report/quantum-computing-for-enterprise-market
iot chip market
https://www.emergenresearch.com/industry-report/iot-chip-market
internet of things insurance market
https://www.emergenresearch.com/industry-report/internet-of-things-insurance-market
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Latest Report: heart rhythm devices market, cancer tumor profiling market
Trending Title: pharmacogenomics market, cell-free dna testing market
